• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: hiv

  • Which HIV Treatment is Best for Patients with HIV and Hepatitis C?
    • in General Medicine
    • — 23 Sep, 2007

    Which HIV Treatment is Best for Patients with HIV and Hepatitis C?

    Juan Berenguer
    Juan Berenguer

    REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    JUAN BERENGUER, Hospital Gregorio Marañón, Madrid
    A retrospective study has thrown doubt on the theory that protease inhibitors (PIs) are a preferable antiretroviral
    …
    Read more
    Entecavir for Hepatitis B Linked to HIV Resistance
    • in General Medicine
    • — 20 Sep, 2007

    Entecavir for Hepatitis B Linked to HIV Resistance

    Moira McMahon
    Moira McMahon

    REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    MOIRA MCMAHON, Johns Hopkins University, Baltimore
    The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for
    …
    Read more
  • Monoclonal Antibody to Help Treat HIV?
    • in General Medicine
    • — 20 Sep, 2007

    Monoclonal Antibody to Help Treat HIV?

    Jeffrey Jacobson
    Jeffrey Jacobson

    REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia
    Could a monoclonal antibody have a role to play in HIV treatment? Early data on the PRO 140
    …
    Read more
    Maraviroc for HIV: Responses at 48 Weeks
    • in General Medicine
    • — 20 Sep, 2007

    Maraviroc for HIV: Responses at 48 Weeks

    Jacob Lalezari
    Jacob Lalezari

    REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    JACOB LALEZARI, Quest Clinical Research, San Francisco
    Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of
    …
    Read more
  • London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007
    • in London School of Hygiene & Tropical Medicine · Public Health
    • — 31 Aug, 2007

    London School of Hygiene & Tropical Medicine Audio News Review, August 31st, 2007

    Philippe Mayaud
    Philippe Mayaud

    Herpes Simplex Therapy Reduces HIV Activity in Co-Infected Patients

    REFERENCE: N Engl J Med 2007; 356: 790-9
    PHILIPPE MAYAUD, London School of Hygiene and Tropical Medicine
    It is possible to reduce HIV activity in patients who are co-infected
    …
    Read more
    London School of Hygiene & Tropical Medicine Audio News Review, August 28th, 2007
    • in London School of Hygiene & Tropical Medicine · Public Health
    • — 30 Aug, 2007

    London School of Hygiene & Tropical Medicine Audio News Review, August 28th, 2007

    Pat Doyle
    Pat Doyle

    Increased Miscarriage Risk in Women with Low Body Mass Index

    REFERENCE: BJOG 2007 114:170
    PAT DOYLE, London School of Hygiene and Tropical Medicine
    Underweight women with a BMI below 18.5 have a 70 per cent increase in their
    …
    Read more
  • London School of Hygiene & Tropical Medicine Audio News
    • in London School of Hygiene & Tropical Medicine · Public Health
    • — 16 Aug, 2007

    London School of Hygiene & Tropical Medicine Audio News

    Simon Lewin
    Simon Lewin

    Adherence to TB Medication

    PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238
    SIMON LEWIN, London School of Hygiene and Tropical Medicine
    A new systematic review has shown that we don’t understand well enough the reasons for poor adherence to tuberculosis medication. Simon
    …
    Read more
    Pneumonia in Children Under One Year: Current Guidelines Not Sufficient
    • in Public Health
    • — 28 May, 2007

    Pneumonia in Children Under One Year: Current Guidelines Not Sufficient

    Lisa McNally

    LISA McNALLY, Institute of Child Health, London, and University of KwaZulu-Natal, Durban

    REFERENCE: The Lancet 2007; 369:1440-1451
    A new study suggests that current guidelines for the treatment of severe pneumonia in children under one year should change. The investigation, which
    …
    Read more
  • Non-Perfect HIV Vaccine Could Still Have Major Benefits
    • in Public Health
    • — 25 May, 2007

    Non-Perfect HIV Vaccine Could Still Have Major Benefits

    Anthony Fauci

    ANTHONY FAUCI, National Institutes of Health, Bethesda

    REFERENCE: N Engl J Med 2007;356:2073-81
    Is there any hope for an HIV vaccine? According to Anthony Fauci, of the National Institutes of Health in Bethesda, there is – but it might
    …
    Read more
    Once-And-For-All TB Assay Brings Cheap, Sensitive, Specific, Seven-Day Diagnosis and Drug-Susceptibility Testing
    • in Public Health
    • — 15 Apr, 2007

    Once-And-For-All TB Assay Brings Cheap, Sensitive, Specific, Seven-Day Diagnosis and Drug-Susceptibility Testing

    David Moore

    DAVID MOORE, Imperial College, London and Lima

    REFERENCE: N Engl J Med 355: 1539-50
    A new test for TB, trialled in Peru, has proved more powerful and yet faster and cheaper than alternatives, making it especially suitable for use in
    …
    Read more
  • 6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates
    • in Public Health
    • — 15 Mar, 2007

    6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates

    Hoosen Coovadia

    HOOSEN COOVADIA, University of KwaZulu-Natal, Durban

    REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
    In the developing world breastfeeding is the recommended infant feeding method, even for women infected with HIV. While early
    …
    Read more
    Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety
    • in Public Health
    • — 13 Mar, 2007

    Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety

    Howard Mayer

    Mark Wainberg

    HOWARD MAYER, Pfizer Global Research, New London CT
    MARK WAINBERG, McGill University, Montreal

    Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
    In a population of treatment-experienced HIV-infected subjects, maraviroc plus optimised background
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: hiv

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.